Osteopontin (Spp1), a known genetic modifier in DMD patients, functions to influence ECM architecture and fibrosis, while Spp1 ablation improves muscle function and influences ECM and macrophage polarization [39–43]. The gene discussed is SPP1; the disease is Duchenne muscular dystrophy.